Background Recent population-based cohort studies suggest that the incidence of systemic
lupus erythematosus (SLE) is increased in patients with immune thrombocytopenic purpura …

Systemic lupus erythematosus (SLE), the prototype of systemic autoimmune diseases is
characterized by extreme heterogeneity with a variable clinical course. Renal involvement …

Anti–CD19 CAR T Cells in Refractory Immune Thrombocytopenia of SLE Page 1 The new
england journal of medicine n engl j med 391;4 nejm.org July 25, 2024 376 Correspondence …

Spleen tyrosine kinase (SYK) is a non-receptor tyrosine kinase. The dysregulation of SYK is
closely related to the occurrence and development of allergic diseases, autoimmune …

Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by immune
dysregulation and organ injury with a premature mortality due to cardiovascular diseases …

BLyS and APRIL have the capability to bind to B cells within the body, allowing these cells to
evade elimination when they should naturally be removed. While BLyS primarily plays a role …

Primary immune thrombocytopenia (ITP) is an acquired autoimmune disorder characterized
by the destruction of platelets. Although it was long believed that the critical role of …

Systemic lupus erythematosus (SLE) predominantly affects child-bearing women, leading to
an elevated risk of maternal and fetal complications and adverse pregnancy outcomes …

Immune thrombocytopenia (ITP) is an autoimmune disease characterized by increased
platelet destruction and impaired production, leading to an elevated bleeding tendency …

A complication of pediatric systemic lupus erythematosus (pSLE) is immune
thrombocytopenia (ITP). Although corticosteroids and immunoglobulins are frequently used …